Business
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
ACTON, Mass., May 26, 2026--Insulet Corporation, Inc. (NASDAQ: PODD) ("Insulet" or the "Company") today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omnipod DASH®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery.
About this update from Insulet Corporation
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":236,"url":"https://media.zenfs.com/en/business-wire.com/4e4bfd0c406ff3ebf75f65588fd46d2c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/HT2VwaQZMBmxXWnE56cXHg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ3Mg--/https://media.zenfs.com/en/business-wire.com/4e4bfd0c406ff3ebf75f65588fd46d2c","width":480,"height":236},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/u2wS2tMBVM4aDc0Cc9ZCNw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMxNQ--/https://media.zenfs.com/en/business-wire.com/4e4bfd0c406ff3ebf75f65588fd46d2c","width":480,"height":236}},"lazy":false},{"type":"text","content":"ACTON, Mass., May 26, 2026--(BUSINESS WIRE)--Insulet Corporation, Inc. (NASDAQ: PODD) ("Insulet" or the "Company") today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omnipod DASH®, and Omnipod® Insulin Management System (Omnipod Eros) Pods due to a manufacturing issue, identified through ongoing product monitoring, that could result in insulin under-delivery.","length":417,"tagName":"p"},{"type":"text","content":"This action is separate from the voluntary Medical Device Correction issued on March 12, 2026 affecting certain Omnipod 5 Pods in the U.S. and includes certain Pod lots distributed in the U.S. and affected international markets. Pods not included in the affected lots remain safe to use.","length":287,"tagName":"p"},{"type":"text","content":"Insulet identified that some Pods from specific lots may have a small tear in the tubing (cannula) just above the skin, between the Pod and the point where the cannula enters the body. If this occurs, insulin may leak outside of the Pod instead of being fully delivered into the body as intended, potentially leading to under-delivery of insulin.","length":346,"tagName":"p"},{"type":"text","content":"Individuals using an affected Pod may notice wetness on their skin or Pod adhesive or detect the smell of insulin. However, in some cases, this issue may be difficult to detect and go unnoticed.","length":194,"tagName":"p"},{"type":"text","content":"If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of insulin. In the most severe cases, prolonged and persistent high bloo...